LatestLicenses And Certifications 9 August 2026
APPC Faces Fire
The APPC is facing criticism for imposing retrospective penalties, portal backlogs, and misuse of statutory powers, affecting the renewal of drug licenses in India, with many license holders experiencing administrative delays, the issue is causing concern among pharmaceutical companies and regulatory bodies, as it may impact the availability of essential medicines in the market
The APPC is under scrutiny for its handling of drug license renewals. Key issues include:
- retrospective penalties imposed on license holders
- portal backlogs causing administrative delays
- misuse of statutory powers.
The problems are affecting the renewal of *drug licenses*, with many license holders experiencing delays. The issue is causing concern among pharmaceutical companies and regulatory bodies, as it may impact the availability of essential medicines in the market
Need help understanding this update?
Connect with our domain experts instantly via WhatsApp for customized legal guidance.
